Letters

Letters

  • Reimbursement and Practice Management

Sort by Recency Sorted by Relevance
Letters

Neurosurgery Responds to FDA Regarding Adverse Event Reporting

Last updated: March 31, 2025
JonnaLynn CapezzutoOffice of OperationsU.S. Food and Drug AdministrationThree White Flint North, 10A–12M11601 Landsdown St.,North Bethesda, MD 20852 Subject: Food and Drug Administration (FDA) Adverse Event and Product Experience Reporting Program […]
  • Drugs and Devices